| 000 | 01332 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517133658.0 | ||
| 264 | 0 | _c20170818 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2016.12.061 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamdy, Rania | |
| 245 | 0 | 0 |
_aSynthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _c02 2017 |
||
| 300 |
_a1037-1040 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOxadiazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 700 | 1 | _aZiedan, Noha I | |
| 700 | 1 | _aAli, Samia | |
| 700 | 1 | _aBordoni, Cinzia | |
| 700 | 1 | _aEl-Sadek, Mohamed | |
| 700 | 1 | _aLashin, Elsaid | |
| 700 | 1 | _aBrancale, Andrea | |
| 700 | 1 | _aJones, Arwyn T | |
| 700 | 1 | _aWestwell, Andrew D | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 27 _gno. 4 _gp. 1037-1040 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2016.12.061 _zAvailable from publisher's website |
| 999 |
_c26784138 _d26784138 |
||